Cannabinoid Mechanisms of Pain Suppression 551Monhemius R, Azami J, Green DL, Roberts MH (2001) CB1 receptor mediated analgesia
from the nucleus reticularis gigantocellularis pars alpha is activated in an animal model
of neuropathic pain. Brain Res 908:67–74
Moreau JL, Fields HL (1986) Evidence for GABA involvement in midbrain control of
medullary neurons that modulate nociceptive transmission. Brain Res 397:37–46
Morisset V, Ahluwalia J, Nagy I, Urban L (2001) Possible mechanisms of cannabinoid-
induced antinociception in the spinal cord. Eur J Pharmacol 429:93–100
Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral
receptor for cannabinoids. Nature 365:61–65
Nackley AG, Makriyannis A, Hohmann AG (2003a) Selective activation of cannabinoid CB2
receptors suppresses spinal Fos protein expression and pain behavior in a rat model of
inflammation. Neuroscience 119:747–757
Nackley AG, Suplita RL 2nd, Hohmann AG (2003b) A peripheral cannabinoid mechanism
suppresses spinal fos protein expression and pain behavior in a rat model of inflamma-
tion. Neuroscience 117:659–670
Nackley AG, Zvonok A, Makriyannis A, Hohmann AG (2004) Activation of cannabinoid
CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range
neurons in the absence and presence of inflammation. J Neurophysiol 92:3562–3574
Nagy JI, Hunt SP (1982) Fluoride-resistant acid phosphatase-containing neurones in dorsal
root ganglia are separate from those containing substance P or somatostatin. Neuro-
science 7:89–97
Nagy JI, Vincent SR, Staines WA, Fibiger HC, Reisine TD, Yamamura HI (1980) Neurotoxic
action of capsaicin on spinal substance P neurons. Brain Res 186:435–444
Neumann S, Doubell TP, Leslie T, Woolf CJ (1996) Inflammatory pain hypersensitivity
mediatedbyphenotypicswitchinmyelinatedprimarysensoryneurons.Nature384:360–
364
Nirodi CS, Crews BC, Kozak KR, Morrow JD, Marnett LJ (2004) The glyceryl ester of
prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7
cells. Proc Natl Acad Sci U S A 101:1840–1845
Noyes R Jr, Brunk SF, Avery DA, Canter AC (1975a) The analgesic properties of delta-9-
tetrahydrocannabinol and codeine. Clin Pharmacol Ther 18:84–89
Noyes R Jr, Brunk SF, Baram DA, Canter A (1975b) Analgesic effect of delta-9-tetrahydro-
cannabinol. J Clin Pharmacol 15:139–143
Oka S, Tsuchie A, Tokumura A, Muramatsu M, Suhara Y, Takayama H, Waku K, Sugiura T
(2003)Ether-linkedanalogueof2-arachidonoylglycerol(noladinether)wasnotdetected
in the brains of various mammalian species. J Neurochem 85:1374–1381
PalazzoE,MarabeseI,deNovellisV,OlivaP,RossiF,BerrinoL,MaioneS(2001)Metabotropic
and NMDA glutamate receptors participate in the cannabinoid-induced antinocicep-
tion. Neuropharmacology 40:319–326
Patel HJ, Birrell MA, Crispino N, Hele DJ, Venkatesan P, Barnes PJ, Yacoub MH, Belvisi
MG (2003) Inhibition of guinea-pig and human sensory nerve activity and the cough
reflex in guinea-pigs by cannabinoid (CB2) receptor activation. Br J Pharmacol 140:261–
268
Pertovaara A, Wei H, Hamalainen MM (1996) Lidocaine in the rostroventromedial medulla
and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci Lett
218:127–130
Pertwee R, Griffin G, Hanus L, Mechoulam R (1994) Effects of two endogenous fatty acid
ethanolamides on mouse vasa deferentia. Eur J Pharmacol 259:115–120
Piomelli D, Beltramo M, Glasnapp S, Lin SY, Goutopoulos A, Xie XQ, Makriyannis A (1999)
Structural determinants for recognition and translocation by the anandamide trans-
porter. Proc Natl Acad Sci U S A 96:5802–5807
Porreca F, Ossipov MH, Gebhart GF (2002) Chronic pain and medullary descending facili-
tation. Trends Neurosci 25:319–325
Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter
P, Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabi-